Uni-Bio Science Group (HKSE:00690) Construction In Progress: HK$69.3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Uni-Bio Science Group Construction In Progress?

Uni-Bio Science Group HKSE:00690 Construction In Progress is HK$69.3 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

Uni-Bio Science Group's quarterly construction in progress declined from Dec. 2024 (HK$50.6 Mil) to Jun. 2025 (HK$9.4 Mil) but then increased from Jun. 2025 (HK$9.4 Mil) to Dec. 2025 (HK$69.3 Mil).

Uni-Bio Science Group's annual construction in progress declined from Dec. 2023 (HK$70.0 Mil) to Dec. 2024 (HK$50.6 Mil) but then increased from Dec. 2024 (HK$50.6 Mil) to Dec. 2025 (HK$69.3 Mil).

Uni-Bio Science Group Construction In Progress Historical Data

* Premium members only.

The historical data trend for Uni-Bio Science Group's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uni-Bio Science Group Construction In Progress Chart

Uni-Bio Science Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.39 13.52 70.03 50.55 69.25

Uni-Bio Science Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.03 16.34 50.55 9.43 69.25

Uni-Bio Science Group Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of HK$69.3 Mil mean?
Uni-Bio Science Group (HKSE:00690) has a Construction In Progress of HK$69.3 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Uni-Bio Science Group and its competitors.
Is Uni-Bio Science Group's Construction In Progress too high?
Uni-Bio Science Group's current Construction In Progress is HK$69.3 Mil.
How does Uni-Bio Science Group's Construction In Progress compare to VRTX and REGN?
Uni-Bio Science Group's Construction In Progress of HK$69.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Uni-Bio Science Group and its competitors. Uni-Bio Science Group's current Construction In Progress is HK$69.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uni-Bio Science Group stock overvalued right now?
Based on GuruFocus' analysis, Uni-Bio Science Group (HKSE:00690) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.09, compared to a current price of HK$0.06 — trading 34.4% below its estimated fair value. The current Construction In Progress is HK$69.3 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Uni-Bio Science Group (HKSE:00690), the current Construction In Progress is HK$69.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Uni-Bio Science Group Business Description

Address No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.